• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Valve-in-valve TAVI and risk of coronary obstruction: Validation of the VIVID classification.

Valve-in-valve TAVI and risk of coronary obstruction: Validation of the VIVID classification.

Details
Files
DOI
10.48350/178563
Publisher DOI
10.1016/j.jcct.2023.01.042
PubMed ID
36754691
Abstract
BACKGROUND

The Valve-in-Valve International Data (VIVID) registry proposed a simplified classification to assess the risk of coronary obstruction during valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) based on preprocedural multi-detector computed tomography (MDCT). We investigated the validity of the VIVID classification in patients undergoing ViV-TAVI for degenerated bioprostheses.

METHODS

Patients undergoing ViV-TAVI for degenerated bioprostheses were prospectively included in this study. The risk of coronary obstruction among patients treated with stented valves was retrospectively evaluated based on anatomical assessment on pre-procedural MDCT.

RESULTS

Among a total of 137 patients that underwent ViV-TAVI between August 2007 and June 2021, 109 patients had stented, sutureless, or transcatheter degenerated bioprosthesis of which 96 (88%) had adequate MDCT data for risk assessment. High-risk anatomy for coronary obstruction (VIVID type IIB, IIIB, or IIIC) in either the left or right coronary artery was observed in 30 patients (31.3%). Of the 30 patients with high-risk anatomy, coronary protection using wire protection or BASILICA (bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction) was performed in 3 patients (10.0%). Three patients treated with stentless valves and one patient treated with a stented valve with externally mounted leaflets had coronary obstruction. None of the patients with high risk anatomy according to MDCT had coronary obstruction even without coronary protection.

CONCLUSIONS

Coronary obstruction occurred in none of the patients classified as high-risk patients according to the VIVID classification despite the absence of coronary protection. Refined tools are required to assess the risk of coronary obstruction.

CLINICAL TRIAL REGISTRATION

https://www.

CLINICALTRIALS

gov. NCT01368250.
Date Issued
2023-02-06
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Subjects
Aortic stenosis Coronary obstruction Transcatheter aortic valve implantation VIVID
Language(s)
en
Author(s)
Tomii, Daijiro  
Universitätsklinik für Kardiologie  
Okuno, Taishi  
Universitätsklinik für Kardiologie  
Lanz, Jonas  
Universitätsklinik für Kardiologie  
Stortecky, Stefan  
Universitätsklinik für Kardiologie  
Reineke, David Christian  
Universitätsklinik für Herzchirurgie  
Windecker, Stephan  
Universitätsklinik für Kardiologie  
Pilgrim, Thomas  
Universitätsklinik für Kardiologie  
Additional Credits
Universitätsklinik für Kardiologie  
Universitätsklinik für Herzchirurgie  
Journal
Journal of cardiovascular computed tomography
Publisher
Elsevier
ISSN
1876-861X
Access(Rights)
Unknown
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 0eaa7c [ 7.08. 11:06]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify